← Leaderboards
David Q Wang
Brigham And Women'S Hospital
$8,354,711
Attributed
$8,354,711
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $844.6K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$8,354,711 · 7
By mechanism
R01$7,726,960 · 5
R21$438,376 · 1
R56$189,375 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Martin Conrad Carey$11,967,389
Others in their field
Top investigators on “Cholelithiasis”
- Richard D Krugman · University Of Colorado Denver$10,694,138
- Martin Conrad Carey · Brigham And Women'S Hospital$8,803,096
- John S Gunn · University Of Texas Hlth Sci Ctr San Ant$8,098,470
- Rodger A. Liddle · Durham Va Medical Center$7,219,239
- Helen H. Hobbs · Ut Southwestern Medical Center$7,038,408
- Nicholas Davidson · Washington University$4,490,940
Research focus
CholelithiasisCholesterolPlayPredispositionGallbladderResponseBaseCrystallizationGenesPhenotypeMediatingLiverHepaticReceptorCholesterol HomeostasisDietPathway InteractionsBile FluidBiliaryInnovationPreventMissionMolecularLiver Diseases
Grant awards (29)
GPR30 and hepatic cholesterol metabolism$468,856
R01 · FY2021 · DK · contact PI
Apolipoprotein A5 and Gallstone Formation$375,750
R01 · FY2021 · DK · contact PI
GPR30 and hepatic cholesterol metabolism$467,461
R01 · FY2020 · DK · contact PI
Apolipoprotein A5 and Gallstone Formation$375,750
R01 · FY2020 · DK · contact PI
Apolipoprotein A5 and Gallstone Formation$375,750
R01 · FY2019 · DK · contact PI
Apolipoprotein A5 and Gallstone Formation$189,979
R01 · FY2018 · DK · contact PI
Apolipoprotein A5 and Gallstone Formation$185,771
R01 · FY2018 · DK · contact PI
Gene therapy of alcoholic liver disease$102,808
R21 · FY2018 · AA · contact PI
Gene therapy of alcoholic liver disease$95,505
R21 · FY2018 · AA · contact PI
GPR30 and Hepatic Cholesterol Homeostasis$334,698
R01 · FY2017 · DK · contact PI
Gene therapy of alcoholic liver disease$240,063
R21 · FY2017 · AA · contact PI
GPR30 and Hepatic Cholesterol Homeostasis$6,177
R01 · FY2017 · DK · contact PI
GPR30 and Hepatic Cholesterol Homeostasis$340,875
R01 · FY2016 · DK · contact PI
GPR30 and Hepatic Cholesterol Homeostasis$340,875
R01 · FY2015 · DK · contact PI
Role of GPR30 in Hepatic Lipid Metabolism$189,375
R56 · FY2014 · DK · contact PI
The Role of Dysfunctional CCK-1R in Cholelithogenesis$312,407
R01 · FY2011 · DK · contact PI
The Role of Dysfunctional CCK-1R in Cholelithogenesis$357,638
R01 · FY2010 · DK · contact PI
The Role of Dysfunctional CCK-1R in Cholelithogenesis$361,250
R01 · FY2009 · DK · contact PI
The Role of Dysfunctional CCK-1R in Cholelithogenesis$361,250
R01 · FY2008 · DK · contact PI
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.$347,528
R01 · FY2008 · DK · contact PI
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.$354,620
R01 · FY2007 · DK · contact PI
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.$365,211
R01 · FY2006 · DK · contact PI
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.$374,000
R01 · FY2005 · DK
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE.$374,000
R01 · FY2004 · DK
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE$256,533
R01 · FY2003 · DK
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE$249,062
R01 · FY2002 · DK
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE$351,297
R01 · FY2001 · DK
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE$131,585
R01 · FY2000 · DK
CHOLESTEROL HOMEOSTASIS IN THE INBRED MOUSE$68,637
R01 · FY2000 · DK